{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:41:11Z","timestamp":1784151671475,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.4158\/ep09340.ra","type":"journal-article","created":{"date-parts":[[2010,5,3]],"date-time":"2010-05-03T21:30:11Z","timestamp":1272922211000},"page":"692-698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pathophysiologic Mechanisms Linking Adipose Tissue and Cardiometabolic Risk"],"prefix":"10.1016","volume":"16","author":[{"given":"Myriam Zaydee","family":"Allende-Vigo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP09340.RA_bb0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14779072.6.3.343","article-title":"Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity","volume":"6","author":"Bays","year":"2008","journal-title":"Exp Rev Cardiovasc Ther"},{"key":"10.4158\/EP09340.RA_bb0015","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archinte.164.3.249","article-title":"The escalating pandemics of obesity and sedentary lifestyle: a call to action for clinicians","volume":"164","author":"Manson","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP09340.RA_bb0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2217\/17460875.1.4.389","article-title":"Adiposopathy: why do adiposity and obesity cause metabolic disease?","volume":"1","author":"Bays","year":"2006","journal-title":"Future Lipidol"},{"key":"10.4158\/EP09340.RA_bb0025","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2337\/dc08-9018","article-title":"Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation","volume":"31","author":"Brunzell","year":"2008","journal-title":"Diabetes Care"},{"key":"10.4158\/EP09340.RA_bb0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-144-7-200604040-00011","article-title":"Adiposity of the heart, revisited","volume":"144","author":"McGavock","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP09340.RA_bb0035","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1373\/clinchem.2007.100156","article-title":"The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences","volume":"54","author":"De Ferranti","year":"2008","journal-title":"Clin Chem"},{"key":"10.4158\/EP09340.RA_bb0040","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.4158\/EP09340.RA_bb0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","article-title":"Endocannabinoid control of food intake and energy balance","volume":"8","author":"Di Marzo","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.4158\/EP09340.RA_bb0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/07853890510037419","article-title":"The endocannabinoid system and the treatment of obesity","volume":"37","author":"Pagotto","year":"2005","journal-title":"Ann Med"},{"key":"10.4158\/EP09340.RA_bb0055","doi-asserted-by":"crossref","first-page":"7P","DOI":"10.1016\/j.amjcard.2007.10.009","article-title":"The endocannabinoid system in the regulation of cardiometabolic risk factors","volume":"100","author":"Bellocchio","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.4158\/EP09340.RA_bb0060","first-page":"99","article-title":"Cross talk between adipose tissue cells: impact on pathophysiology","volume":"17","author":"Schling","year":"2002","journal-title":"News Physiol Sci"},{"key":"10.4158\/EP09340.RA_bb0065","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/01.hco.0000240586.76344.f5","article-title":"The prevention and treatment of metabolic syndrome and high-risk obesity","volume":"21","author":"Molavi","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.4158\/EP09340.RA_bb0070","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1742-1241.2008.01848.x","article-title":"Is adiposopathy (sick fat) an endocrine disease?","volume":"62","author":"Bays","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.4158\/EP09340.RA_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1192044","article-title":"Adipose tissue dysfunction in obesity","volume":"117","author":"Bl\u00fcher","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.4158\/EP09340.RA_bb0080","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","article-title":"Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study","volume":"1116","author":"McGavock","year":"2007","journal-title":"Circulation"},{"key":"10.4158\/EP09340.RA_bb0085","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1001\/archinte.160.14.2117","article-title":"Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study","volume":"160","author":"Folsom","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.4158\/EP09340.RA_bb0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/14796678.1.1.39","article-title":"Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia","volume":"1","author":"Bays","year":"2005","journal-title":"Future Cardiol"},{"key":"10.4158\/EP09340.RA_bb0095","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/jc.2007-2191","article-title":"Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men","volume":"93","author":"Cartier","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09340.RA_bb0100","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1210\/jc.2004-0518","article-title":"Adiponectin: a novel adipokine linking adipocytes and vascular function","volume":"89","author":"Goldstein","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09340.RA_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cardiores.2006.10.009","article-title":"Adiponectin actions in the cardiovascular system","volume":"74","author":"Hopkins","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.4158\/EP09340.RA_bb0110","doi-asserted-by":"crossref","first-page":"68B","DOI":"10.1016\/j.amjcard.2006.11.007","article-title":"Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction","volume":"99","author":"Lee","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.4158\/EP09340.RA_bb0115","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/bmj.322.7288.716","article-title":"Treatment of obesity: need to focus on high risk abdominally obese patients","volume":"322","author":"Despr\u00e9s","year":"2001","journal-title":"BMJ"},{"key":"10.4158\/EP09340.RA_bb0120","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.4158\/EP09340.RA_bb0125","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.4158\/EP09340.RA_bb0130","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA."},{"key":"10.4158\/EP09340.RA_bb0135","first-page":"e297","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement [published corrections appear in","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.4158\/EP09340.RA_bb0140","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","article-title":"Metabolic origins and clinical significance of LDL heterogeneity","volume":"43","author":"Berneis","year":"2002","journal-title":"J Lipid Res"},{"key":"10.4158\/EP09340.RA_bb0145","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/01.HYP.0000101686.98973.A3","article-title":"Obesity, sleep apnea, and hypertension","volume":"42","author":"Wolk","year":"2003","journal-title":"Hypertension"},{"key":"10.4158\/EP09340.RA_bb0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.jhh.1002103","article-title":"Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity\/insulin resistance?","volume":"21","author":"Sarafidis","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.4158\/EP09340.RA_bb0155","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/ndt\/gfl019","article-title":"Inflammation and hypertension: the search for a link","volume":"21","author":"Pauletto","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.4158\/EP09340.RA_bb0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1525-1381.1999.99231.x","article-title":"The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes","volume":"111","author":"Sobel","year":"1999","journal-title":"Proc Assoc Am Physicians"},{"key":"10.4158\/EP09340.RA_bb0165","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/diab.43.1.104","article-title":"Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients","volume":"43","author":"McGill","year":"1994","journal-title":"Diabetes"},{"key":"10.4158\/EP09340.RA_bb0170","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/jc.2003-030723","article-title":"Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach","volume":"89","author":"Bays","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09340.RA_bb0175","doi-asserted-by":"crossref","first-page":"21J","DOI":"10.1016\/S0002-9149(99)00353-7","article-title":"Insulin signaling in the arterial wall","volume":"84","author":"Hsueh","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.4158\/EP09340.RA_bb0180","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.4158\/EP09340.RA_bb0185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-8529(05)70324-8","article-title":"The cellular and molecular mechanisms of diabetic complications","volume":"25","author":"King","year":"1996","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.4158\/EP09340.RA_bb0190","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","article-title":"Obesity-induced inflammatory changes in adipose tissue","volume":"112","author":"Wellen","year":"2003","journal-title":"Clin Invest"},{"key":"10.4158\/EP09340.RA_bb0195","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","article-title":"Adipokines: molecular links between obesity and atherosclerosis","volume":"288","author":"Lau","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.4158\/EP09340.RA_bb0200","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/01.HYP.0000163475.04421.e4","article-title":"Mechanisms of insulin resistance in humans and possible links with inflammation","volume":"45","author":"Savage","year":"2005","journal-title":"Hypertension"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20408092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20408092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/1427X07125K84148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:50:47Z","timestamp":1761515447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20408092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1530891X20408092"],"URL":"https:\/\/doi.org\/10.4158\/ep09340.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiologic Mechanisms Linking Adipose Tissue and Cardiometabolic Risk","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP09340.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}